Skip to Content

The randomized DYNAMIC Trial: ctDNA-guided approach towards adjuvant chemotherapy

Should we have a circulating tumor DNA (ctDNA)-guided approach towards adjuvant chemotherapy in patients with stage II colon cancer? Let Jeanne Tie, Medical Oncologist, update you on the area by the latest results from the randomized DYNAMIC trial.

Jeanne Tie

Get access to the article

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top